Connecticut Pharmaceutical Association
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2012 | 495,715 | 582,532 | −86,817 | 8.3 | 35% |
| 2013 | 411,611 | 513,351 | −101,740 | 7.1 | 41% |
| 2014 | 541,611 | 556,108 | −14,497 | 6.9 | 33% |
| 2015 | 415,503 | 459,277 | −43,774 | 7.0 | 41% |
| 2016 | 391,060 | 420,700 | −29,640 | 8.6 | 46% |
| 2017 | 484,197 | 481,032 | 3,165 | 8.0 | 44% |
| 2018 | 437,162 | 439,217 | −2,055 | 8.8 | 13% |
| 2019 | 379,388 | 509,091 | −129,703 | 4.6 | 25% |
| 2020 | 409,426 | 438,529 | −29,103 | 4.3 | 36% |
| 2021 | 300,431 | 391,698 | −91,267 | 3.2 | 44% |
| 2022 | 364,792 | 448,707 | −83,915 | -0.5 | 49% |
| 2023 | 333,276 | 333,748 | −472 | -0.1 | 55% |
| 2024 | 364,781 | 386,287 | −21,506 | -0.3 | 52% |
In its most recent public year (2024), this organization spent $21,506 more than it brought in. Its liabilities exceeded its net assets — reserves were below zero (-0.3 months), down from 8.3 in 2012. Staff pay was 52% of spending.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2024. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
A new entry when its next filing is released. No account, no email; works in any feed reader, Slack, or automation tool. How following works